An international team of experts has published evidence-based recommendations for how to best treat people with neuromyelitis optica spectrum…
Articles by Marisa Horak, MS
Eating more oily fish and raw vegetables may decrease a person’s risk of developing neuromyelitis optica spectrum disorder (NMOSD),…
Committee-based assessments are reliable for identifying disease attacks in people with neuromyelitis optica spectrum disorder (NMOSD) in the N-MOmentum…
Ultomiris (ravulizumab) has been approved by the European Commission to treat adults with neuromyelitis optica spectrum disorder (NMOSD)…
Antibodies against aquaporin-4 (AQP4) are detectable in the blood several years before symptoms occur in most people with neuromyelitis…
Experts in Germany have published recommendations to help clinicians diagnose neuromyelitis optica spectrum disorder (NMOSD) and distinguish it from…
Living with neuromyelitis optica spectrum disorder (NMOSD) and resulting disability can make it hard to find and keep employment,…
A European Medicines Agency (EMA) committee has recommended that Ultomiris (ravulizumab) be approved to treat adults with neuromyelitis optica spectrum…
Uplizna (inebilizumab) reduces the formation of asymptomatic lesions in the nerves that connect the eyes to the brain in…
The annual prevalence of neuromyelitis optica spectrum disorder (NMOSD) in the U.S. is considerably higher than previously estimated, affecting…